3D-bioprinted tumour models for cancer drug screening.
| Date | Round | Amount |
|---|---|---|
| Jan 2024 | Funding round Edinburgh biotech Carcinotech raised £4.2M led by Eos Advisory for its 3D-bioprinted tumour models. | $5.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.